Related Experiment Video
Updated: Sep 19, 2025
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity
Pradip K Saha1,2, Robert Sharp1, Aaron R Cox3
1Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine and.
Abstract:
White adipose tissue (WAT) fibrosis occurring in obesity contributes to the inflammatory and metabolic comorbidities of insulin resistance and type 2 diabetes, yet the mechanisms involved remain poorly understood. Here, we report a role for the broadly conserved miRNA miR-30a as a regulator of WAT fibrosis and systemic glucose metabolism. Mice modified to express miR-30a at elevated levels in adipose tissues maintain insulin sensitivity coupled with reduced fatty liver disease when fed a high-fat diet. These effects were attributable to cell-autonomous functions of miR-30a that potently increase expression of adipocyte-specific genes. Proteomic screening revealed miR-30a limits profibrotic programs in subcutaneous WAT, at least in part, by repressing PAI-1, a dominant regulator of fibrinolysis and biomarker of insulin resistance. Conversely, mouse adipocytes lacking miR-30a exhibited greater expression of fibrosis markers with disrupted cellular metabolism. Lastly, miR-30a expression negatively correlates with PAI-1 levels in subcutaneous WAT from people with obesity, further supporting an antifibrotic role for miR-30a. Together, these findings uncover miR-30a as a critical regulator of adipose tissue fibrosis that predicts metabolically healthy obesity in people and mice.
Insights
MicroRNA miR-30a prevents white adipose tissue fibrosis, improving insulin sensitivity and metabolic health in obesity. This finding suggests miR-30a is key to understanding and treating metabolic disorders.
Area of Science:
- Molecular Biology
- Metabolic Disease Research
- Adipose Tissue Biology
Background:
- White adipose tissue (WAT) fibrosis is linked to obesity, insulin resistance, and type 2 diabetes.
- Mechanisms underlying WAT fibrosis and its metabolic consequences are not fully understood.
Purpose of the Study:
- To investigate the role of microRNA miR-30a in regulating white adipose tissue fibrosis and systemic glucose metabolism.
- To explore the therapeutic potential of miR-30a in metabolic health.
Main Methods:
- Mice with elevated adipose tissue miR-30a expression were studied under high-fat diet conditions.
- Proteomic screening was used to identify targets of miR-30a in WAT.
- Expression analysis of fibrosis markers and metabolic genes in adipocytes with altered miR-30a levels.
- Correlation analysis of miR-30a and PAI-1 in human subcutaneous WAT samples from individuals with obesity.
Main Results:
- Overexpression of miR-30a in mice improved insulin sensitivity and reduced fatty liver disease on a high-fat diet.
- miR-30a enhanced adipocyte-specific gene expression and limited profibrotic programs by repressing PAI-1.
- Loss of miR-30a in mouse adipocytes increased fibrosis markers and disrupted cellular metabolism.
- Human WAT showed an inverse correlation between miR-30a expression and PAI-1 levels in obesity.
Conclusions:
- miR-30a acts as a critical regulator of adipose tissue fibrosis and systemic glucose metabolism.
- miR-30a has an antifibrotic role in WAT, potentially predicting metabolically healthy obesity.
- Targeting miR-30a may offer a novel therapeutic strategy for obesity-related metabolic complications.
